Education
About Us
Working with TipRanks
Follow Us
Fresenius Se (FSNUY)
:FSNUY
FSNUY Stock Chart & Stats
$14.04
$0.06(0.63%)
At close: 4:00 PM EST
$14.04
$0.06(0.63%)
Day’s Range― - ―
52-Week Range$8.47 - $14.74
Previous CloseN/A
Volume6.04K
Average Volume (3M)5.22K
Market Cap
$31.58B
Enterprise Value$45.26B
Total Cash (Recent Filing)$1.39B
Total Debt (Recent Filing)$12.85B
Price to Earnings (P/E)25.0
Beta0.18
Next Earnings
Feb 25, 2026EPS Estimate
0.27Last Dividend Ex-Date
May 27, 2025Dividend Yield2%
Share Statistics
EPS (TTM)0.24
Shares Outstanding2,252,949,200
10 Day Avg. Volume3,154
30 Day Avg. Volume5,216
Financial Highlights & Ratios
PEG Ratio-0.89
Price to Book (P/B)3.90
Price to Sales (P/S)3.49
P/FCF Ratio49.97
Enterprise Value/Market Cap1.43
Enterprise Value/Revenue2.04
Enterprise Value/Gross Profit8.02
Enterprise Value/Ebitda13.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.98
Revenue Forecast (FY)$26.07B
Fresenius SE & Co News
FSNUY FAQ
What was Fresenius Se’s price range in the past 12 months?
Fresenius Se lowest stock price was $8.47 and its highest was $14.74 in the past 12 months.
What is Fresenius Se’s market cap?
Fresenius Se’s market cap is $31.58B.
When is Fresenius Se’s upcoming earnings report date?
Fresenius Se’s upcoming earnings report date is Feb 25, 2026 which is in 99 days.
How were Fresenius Se’s earnings last quarter?
Fresenius Se released its earnings results on Nov 05, 2025. The company reported $0.236 earnings per share for the quarter, beating the consensus estimate of $0.208 by $0.028.
Is Fresenius Se overvalued?
According to Wall Street analysts Fresenius Se’s price is currently Overvalued.
Does Fresenius Se pay dividends?
Fresenius Se pays a Annually dividend of $0.283 which represents an annual dividend yield of 2%. See more information on Fresenius Se dividends here
What is Fresenius Se’s EPS estimate?
Fresenius Se’s EPS estimate is 0.27.
How many shares outstanding does Fresenius Se have?
Fresenius Se has 2,252,949,200 shares outstanding.
What happened to Fresenius Se’s price movement after its last earnings report?
Fresenius Se reported an EPS of $0.236 in its last earnings report, beating expectations of $0.208. Following the earnings report the stock price went down -1.076%.
Which hedge fund is a major shareholder of Fresenius Se?
Currently, no hedge funds are holding shares in FSNUY
Fresenius SE & Co Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
65.74%
12-Months-Change
Fundamentals
Return on Equity
7.22%
Trailing 12-Months
Asset Growth
5.51%
Trailing 12-Months
Company Description
Fresenius Se
Fresenius SE & Co. KGaA is a global healthcare group based in Germany, operating primarily in the sectors of healthcare, particularly dialysis, hospital management, and pharmaceuticals. The company is structured into several business segments, including Fresenius Medical Care, which focuses on dialysis products and services; Fresenius Helios, which operates private hospitals; and Fresenius Kabi, which specializes in intravenous therapies and clinical nutrition. The company’s core offerings include dialysis machines, consumables, hospital management services, and a wide range of generic drugs and medical devices.
FSNUY Company Deck
FSNUY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Fresenius demonstrated strong performance across its core businesses, with significant EPS growth and an EBIT guidance upgrade. Despite facing macroeconomic and geopolitical challenges, the company maintained strong operational execution, particularly in its Kabi and biopharma segments. The DRG inflator in Germany and U.S. tariffs present potential headwinds, but the overall momentum remains positive.View all FSNUY earnings summariesTechnical Analysis
DaVita
―
Fresenius Medical Care
―
HCA Healthcare
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---